京新藥業(002020.SZ)引進醫療器械產品“一體式人工大血管”
格隆匯 7 月 23日丨京新藥業(002020.SZ)公佈,近日,公司與武漢麥迪領科醫療科技有限公司(“麥迪領科”)、陶涼簽訂《戰略合作協議》,就“一體式人工大血管”產品進行研發合作及商業化推進,項目總投資約為5000萬元。
“一體式人工大血管”是由麥迪領科和陶涼共同研發設計的一款應用於急性主動脈夾層A型手術的產品。目前在急性主動脈夾層A型手術中,使用傳統人工血管+覆膜支架,術中需深低温停循環20~30min進行大血管吻合。該產品通過一體化設計及免縫合襯裙裝置,大大縮短停循環操作時間,避免因深低温停循環導致的腦部和肝腎併發症,降低術後死亡率。同時,由於急性主動脈夾層A型手術難度大,目前主要集中在一二線城市及各省會城市的大型三甲醫院,手術普及率低,很多患者無法得到及時有效治療,該產品可以簡化手術流程,縮短醫生的學習曲線,有利於提高手術在三級以上醫院的普及度,使更多患者受益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.